Deciphering the mechanism of action of VP343, an antileishmanial drug candidate, in Leishmania infantum
Summary: Antileishmanial chemotherapy is currently limited due to severe toxic side effects and drug resistance. Hence, new antileishmanial compounds based on alternative approaches, mainly to avoid the emergence of drug resistance, are needed. The present work aims to decipher the mechanism of acti...
Principais autores: | Sameh Obeid, Eloisa Berbel-Manaia, Valérie Nicolas, Indira Dennemont, Julien Barbier, Jean-Christophe Cintrat, Daniel Gillet, Philippe M. Loiseau, Sébastien Pomel |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
Elsevier
2023-11-01
|
coleção: | iScience |
Assuntos: | |
Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S2589004223022216 |
Registros relacionados
-
Antileishmanial activity of terpenylquinones on Leishmania infantum and their effects on Leishmania topoisomerase IB
por: Yolanda Pérez-Pertejo, et al.
Publicado em: (2019-12-01) -
Leishmania infantum asymptomatic infection in inflammatory bowel disease patients under anti-TNF therapy
por: M. Carmen Guillén, et al.
Publicado em: (2020-05-01) -
Leishmania amazonensis sabotages host cell SUMOylation for intracellular survival
por: Kendi Okuda, et al.
Publicado em: (2022-09-01) -
Antileishmanial Activity of BNIPDaoct- and BNIPDanon-loaded Emulsomes on Leishmania infantum Parasites
por: Zeynep Islek, et al.
Publicado em: (2022-01-01) -
The different impact of drug-resistant Leishmania on the transcription programs activated in neutrophils
por: Míriam Díaz-Varela, et al.
Publicado em: (2024-05-01)